A Study Using Olaparib Tablets for Subjects With Advanced Solid Tumours.

NCT03553108 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Solid Tumor

Interventions

DRUG: Olaparib Treatment A
DRUG: Olaparib Treatment B
DRUG: Olaparib Treatment C
DRUG: Olaparib Treatment D

Sponsor

AstraZeneca

Collaborators

[object Object]
[object Object]